PAHC — Phibro Animal Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual income statement for Phibro Animal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2019 June 30th	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	828	800	833	942	978
Cost of Revenue
Gross Profit	265	257	271	285	298
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	745	731	758	863	906
Operating Profit	83.2	69.2	74.9	79	71.8
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	71.5	55.5	66.5	72.3	54.1
Provision for Income Taxes
Net Income After Taxes	54.4	33.6	54.4	49.2	32.6
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	54.7	33.6	54.4	49.2	32.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	54.7	33.6	54.4	49.2	32.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.32	0.804	1.34	1.22	0.908
Dividends per Share